Co-Oximetry EQA | RIQAS
Co-Oximetry EQA | RIQAS
The RIQAS CO-Oximetry EQA programme is a comprehensive programme suitable for monitoring the performance of 7 CO-Oximetry parameters. All samples are supplied in a lyophilised format, providing greater stability and ensuring clinically relevant levels.
- Lyophilised
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9177 * | 6 x 1ml | Monthly (1 x 12 month cycle) | 7 | |
| RQ9177/A ** | 6 x 1ml | Monthly (1 x 12 month cycle) | 7 | |
Note to participants with multiple instruments on the CO-Oximetry Programme:
RQ9177 must be purchased for the first registered instrument and individual RQ9177/A kits purchased for each subsequently registered instrument.
Please note, product availability may vary country to country.
Parameters
- Carboxyhaemoglobin (COHb / HbCO)
- Deoxyhaemoglobin (RHb / HHb)
- Methaemoglobin (MetHb)
- Oxygen Content (O2CT)
- Oxygen Saturation (sO2 / Vol O2)
- Oxyhaemoglobin (O2Hb / HbO2)
- Total Haemoglobin (tHb)
About CO-Oximetry EQA
Co-oximetry is a methodology, also known as spectrophotometry, that measures the levels of the oxygen-carrying protein haemoglobin, which is the chief component of red blood cells. Co-oximetry is a useful tool in that it helps determine the levels of various forms of haemoglobin.
Spectrophotometric methods date back to studies by Sir Isaac Newton in the 1600s. Work by Lambert (1760) and Beer (1852) resulted in the Beer-Lambert law which describes the transmission / absorption of light in solutions (Chatburn, 2014).
A high value for the Co-Oximetry Blood Test may indicate, among other things:
- Carbon monoxide poisoning
- Congenital haemoglobin disorder
Related Products
Coagulation External Quality Assessment
The RIQAS Coagulation EQA programme is designed to monitor the performance of 17 routine coagulation tests and specialised factor assays. Two flexible yet cost effective programme options are available.
- Accredited to ISO/IEC 17043:2010
- Lyophilised for enhanced stability
- 100% human plasma
- Monthly reporting
- Choose between 5 routine parameters or all 17 parameters
- Submit results and view reports online via RIQASNet
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9135/a | 12 x 1ml | Monthly (1 x 12 month cycle) | 5 parameters (aPTT, PT, TT, Fibrinogen and ATIII) | |
| RQ9135/b | 12 x 1ml | Monthly (1 x 12 month cycle) | All 17 parameters | |
Routine Parameters
- aPTT
- PT (including INR)
- TT
- Fibrinogen
- Antithrombin III
Parameters
- aPTT
- PT (including INR)
- TT
- Fibrinogen
- Antithrombin III
- Plasminogen
- Protein C
- Protein S
- Factor II
- Factor V
- Factor VII
- Factor VIII
- Factor IX
- Factor X
- Factor XI
- Factor XII
- D-dimer*
* – Pilot study ongoing
Please note, product availability may vary country to country.
Related Products
Toxicology External Quality Assessment
The RIQAS Urine Toxicology EQA programme is designed to monitor the performance of 20 drugs of abuse tests in urine. Suitable for both qualitative and semi-quantitative methods of analysis.
- Liquid ready-to-use
- 100% human urine
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Suitable for use with both quantitative and screening methods
- Report results for drug group or individual metabolite
- Cycle Starts – January 2025
Not accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9139 | 12 x 5ml | Monthly (1 x 12 month cycle) | 20 | |
Parameters
- Benzoylegonine
- Buprenorphine
- Cannabinoids (THC)
- Cotinine
- Creatinine
- d-Amphetamine
- d-Methamphetamine
- EDDP
- Ethanol
- Free Morphine
- Lorazepam
- LSD
- MDMA
- Methadone
- Norpropoxyphene
- Nortryptyline
- Oxazepam
- Phencyclidine
- Phenobarbital
- Secobarbital
Please note, product availability may vary country to country.
Maternal Screening External Quality Assessment
The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down’s syndrome, Spina Bifida and Trisomy 18.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Suitable for first and second trimester screening
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9137 | 12 x 1ml | Monthly (1 x 12 month cycle) | 6 | |
Parameters
- AFP
- free β-hCG
- Total hCG
- Inhibin A
- PAPP-A
- Unconjugated Oestriol
Please note, product availability may vary country to country.
Related Products
Cardiac Plus External Quality Assessment
The RIQAS Cardiac Plus EQA programme is designed to monitor the performance of 11 clinically significant cardiac markers. All samples are supplied in a lyophilised format.
- Accredited to ISO/IEC 17043
- Lyophilised
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments at no extra cost
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9190 | 12 x 3ml | Monthly (1 x 12 month cycle) | 11 parameters | |
Parameters
- CK, Total
- CK-MB (Activity)
- CK-MB (Mass)
- D-dimer
- Digoxin
- Homocysteine
- hsCRP
- Myoglobin
- NT-proBNP
- Troponin I
- Troponin T
Please note, product availability may vary country to country.
Immunoassay Speciality 2 External Quality Assessment
The RIQAS Immunoassay Speciality 2 EQA programme is designed to monitor the performance of 5 complex, specialised immunoassay parameters.
- Lyophilised for enhanced stability
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Accredited to ISO/IEC 17043
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9142 | 12 x 1ml | Monthly Reporting (1 x 12 month cycle) | 5 | |
Parameters
- Calcitonin
- Gastrin
- Procalcitonin
- Plasma Renin Activity
- Renin (Direct Concentration)
Please note, product availability may vary country to country.
Related Products
Immunoassay Speciality I External Quality Assessment
The RIQAS Immunoassay Speciality I EQA programme is designed to monitor the performance of 10 complex, specialised immunoassay parameters including procalcitonin and vitamin D.
- Lyophilised for enhanced stability
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Accredited to ISO/IEC 17043
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9141 | 12 x 2ml | Monthly Reporting (1 x 12 month cycle) | 10 | |
Parameters
- 1-25-OH-Vitamin D*
- 25-OH-Vitamin D
- Anti-TG
- Anti-TPO
- C-peptide
- IGF-1
- Insulin
- Osteocalcin
- Procalcitonin
- PTH
*Pilot study ongoing
Please note, product availability may vary country to country.
Related Products
HbA1c External Quality Assessment
The RIQAS Glycated Haemoglobin (HbA1c) EQA programme is designed to monitor the performance of HbA1c and Total Haemoglobin assays.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% whole blood
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9129 | 12 x 0.5ml | Monthly (6 samples per distribution, 2 distributions per cycle) | 2 | |
Parameters
- HbA1c
- Total Haemoglobin
Please note, product availability may vary country to country.
Related Products
BNP External Quality Assessment
The RIQAS BNP programme is a dedicated programme suitable for monitoring the performance of B-type Natriuretic Peptide. All samples are supplied in a liquid ready-to-use format, therefore reducing the amount of preparation time required and reducing the risk of human error.
- Liquid ready-to-use
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Cycle Starts – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9165 | 12 x 1ml | Monthly | 1 | |
Order with RQ9136/a when BNP and Liquid Cardiac parameters required
Parameters
- BNP
Please note, product availability may vary country to country.
Related Products
RIQAS Blood Gas External Quality Assessment
The RIQAS Blood Gas programme is a comprehensive EQA programme suitable for monitoring the performance of 11 blood gas parameters. All samples are supplied in a liquid ready-to-use format ideal for both clinical and point-of-care testing (POCT).
- Accredited to ISO/IEC 17043
- Liquid ready-to-use
- Aqueous material
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Suitable for POCT
- Cycles Start – January 2025
| Cat No | Kit Size | Frequency | Parameters | |
|---|---|---|---|---|
| RQ9134 | 12 x 1.8ml | Monthly (1 x 12 month cycle) | 11 | |
| RQ9134/A | 12 x 1.8ml | Monthly (1 x 12 month cycle) | 11 | |
Parameters
- Bicarbonate
- pCO2
- pH
- pO2
- CO2(Total)
- Ca++
- Cl-
- K+
- Na+
- Glucose
- Lactate
Please note, product availability may vary country to country.